Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: |
Title | Recombination |
Description | Precision More Precision oncology Precision oncology Precision oncology Precision oncology Targeting DNA damage response (DDR) pathways Partnering About Us Recombin |
Keywords | N/A |
WebSite | recombinationtx.com |
Host IP | 198.71.232.3 |
Location | United States |
Site | Rank |
US$1,005
Last updated: 2023-05-08 08:26:19
recombinationtx.com has Semrush global rank of 0. recombinationtx.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. recombinationtx.com receives approximately 116 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, recombinationtx.com is safe to visit. |
Purchase/Sale Value | US$1,005 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$27 |
Yearly Ads Revenue | US$334 |
Daily Unique Visitors | 7 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
recombinationtx.com. | A | 3599 | IP: 198.71.232.3 |
recombinationtx.com. | NS | 3600 | NS Record: ns59.domaincontrol.com. |
recombinationtx.com. | NS | 3600 | NS Record: ns60.domaincontrol.com. |
recombinationtx.com. | MX | 3600 | MX Record: 0 recombinationtx-com.mail.protection.outlook.com. |
recombinationtx.com. | TXT | 3600 | TXT Record: NETORGFT4315288.onmicrosoft.com |
recombinationtx.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
More Precision oncology Precision oncology Precision oncology Precision oncology Targeting DNA damage response (DDR) pathways Partnering About Us Recombination Therapeutics (RTx) is a precision oncology company dedicated to developing next-generation precision medicines for cancer patients by targeting DDR pathways DNA polymerase Theta (Polq) Polq is a multi-functional DNA repair factor that is essential for the survival of homologous recombination (HR) deficient cancer cells, such as those mutated in the BRCA1/2 tumor suppressor proteins. Polq is dispensable for normal cells, and is therefore an ideal drug target. Polq also promotes cellular resistance to various cancer therapies, such as ionizing radiation, topoisomerase inhibitors and PARP inhibitors. RTx is currently performing drug lead optimization. Undisclosed target Many cancer types exhibit high levels of replicative stress, and inducing replicative stress can induce cancer cell death, especially when DNA damage responses are |
HTTP/1.1 301 Moved Permanently location: https://recombinationtx.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Fri, 29 Oct 2021 16:43:36 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 cache-control: max-age=30 content-security-policy: frame-ancestors 'self' content-type: text/html;charset=utf-8 vary: Accept-Encoding content-length: 40942 server: DPS/1.12.0 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Fri, 29 Oct 2021 16:43:36 GMT |
Domain Name: RECOMBINATIONTX.COM Registry Domain ID: 2248582760_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-07T18:44:47Z Creation Date: 2018-04-06T12:53:37Z Registry Expiry Date: 2022-04-06T12:53:37Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS59.DOMAINCONTROL.COM Name Server: NS60.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T05:32:31Z <<< |